1. Home
  2. RMT vs ALDX Comparison

RMT vs ALDX Comparison

Compare RMT & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMT
  • ALDX
  • Stock Information
  • Founded
  • RMT 1993
  • ALDX 2004
  • Country
  • RMT United States
  • ALDX United States
  • Employees
  • RMT N/A
  • ALDX N/A
  • Industry
  • RMT Investment Managers
  • ALDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RMT Finance
  • ALDX Health Care
  • Exchange
  • RMT Nasdaq
  • ALDX Nasdaq
  • Market Cap
  • RMT 453.1M
  • ALDX 398.3M
  • IPO Year
  • RMT N/A
  • ALDX 2014
  • Fundamental
  • Price
  • RMT $8.47
  • ALDX $5.33
  • Analyst Decision
  • RMT
  • ALDX Strong Buy
  • Analyst Count
  • RMT 0
  • ALDX 2
  • Target Price
  • RMT N/A
  • ALDX $10.00
  • AVG Volume (30 Days)
  • RMT 111.5K
  • ALDX 968.5K
  • Earning Date
  • RMT 01-01-0001
  • ALDX 05-01-2025
  • Dividend Yield
  • RMT 7.37%
  • ALDX N/A
  • EPS Growth
  • RMT N/A
  • ALDX N/A
  • EPS
  • RMT 1.49
  • ALDX N/A
  • Revenue
  • RMT N/A
  • ALDX N/A
  • Revenue This Year
  • RMT N/A
  • ALDX N/A
  • Revenue Next Year
  • RMT N/A
  • ALDX N/A
  • P/E Ratio
  • RMT $6.18
  • ALDX N/A
  • Revenue Growth
  • RMT N/A
  • ALDX N/A
  • 52 Week Low
  • RMT $7.67
  • ALDX $3.10
  • 52 Week High
  • RMT $9.51
  • ALDX $7.20
  • Technical
  • Relative Strength Index (RSI)
  • RMT 36.10
  • ALDX 36.30
  • Support Level
  • RMT $8.24
  • ALDX $5.04
  • Resistance Level
  • RMT $8.63
  • ALDX $6.73
  • Average True Range (ATR)
  • RMT 0.14
  • ALDX 0.54
  • MACD
  • RMT 0.02
  • ALDX -0.17
  • Stochastic Oscillator
  • RMT 41.07
  • ALDX 13.97

About RMT Royce Micro-Cap Trust Inc.

Royce Micro-Cap Trust Inc is a diversified closed-end investment company. The company is engaged in investing in micro-cap securities. It invests in the consumer discretionary sector including auto components, automobiles, diversified consumer services, hotels, restaurants and leisure, household durables, internet and catalog retail, leisure products, media, multiline retail, textiles, apparels, and luxury goods, Consumer staples sector including beverages, food, and staples retailing, food products, and personal products, Energy sector including energy equipment and services, and oil, gas, and consumable fuels. The company also invests in other sectors including healthcare, financials, industrials, IT, telecommunications, and materials.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: